Poster
No. |
Presenter |
Title |
P-06 |
Hiroshi Arai
[Tokyo Medical and Dental Univ.] |
Development of small CD4 mimic molecules that induce conformational
changes in gp120 |
|
P-07 |
Taro Ozaki
[Tokyo Medical and Dental Univ.] |
Structure-activity relationships of CXCR4 antagonists having the dipicolylamine/azamacro- cyclic-metal complex structures |
|
P-08 |
Taisuke Izumi
[Kyoto Univ.] |
Model structure of APOBEC3G N-terminal region reveals a biding pocket
modulating HIV-1 Vif interaction and RNA required for encapsidation |
|
P-09 |
Terumasa Ikeda
[Kumamoto Univ.] |
Identification of the functional region required for anti-HIV-1 activity of
APOBEC1 |
|
P-10 |
Kazuhiko Maeda
[Kumamoto Univ.] |
GANP regulates the incorporation of Apobec3G into HIV-1 virions |
|
P-11 |
Natsuko Inagaki
[Univ. of Tokyo] |
Critical amino acid residues for functional interaction between N-terminal
and C-terminal domains in SIV capsid proteins |
|
P-12 |
Ken Kono
[Osaka Univ.] |
Simian-tropic HIV-1 NL-4/5S6/7SvifS shows slower capsid uncoating in
human cells |
|
P-13 |
Takeo Kuwata
[Kumamoto Univ.] |
Isolation of monoclonal neutralizing antibodies from SIV-infected
macaques by phage display |
|
P-14 |
Sayaka Sukegawa
[Tokyo Medical and Dental Univ.] |
Involvement of suppressor of cytokine signaling 1 (SOCS1) protein in the
Rhesus Macaque TRIM5-mediated restriction of HIV-1 production |
|
P-15 |
Tomoko Kobayashi
[Kyoto Univ.] |
Live cell-based mutagenesis studies reveals the structural insights for
human tetherin recognition by HIV-1 Vpu |
|
P-16 |
Youichi Ogawa
[Univ. of Yamanashi] |
Production of LL-37 during herpes simplex virus types 2 infection in
human keratinocytes enhances HIV susceptibility in Langerhans cells, but
not in Dendritic cells |
|
P-17 |
Teppei Toda
[Kumamoto Univ.] |
A novel anti-CD4 monoclonal antibody that inhibits HIV-1 membrane
fusion |
|
P-18 |
Shigeyoshi Harada
[Kumamoto Univ.] |
Evolution and selection of the env gene of HIV-1 primary isolates during in
vitro selection of raltegravir |
|
P-19 |
Kensaku Anraku
[Kumamoto Health Science
Univ.] |
Exploration of small molecules that bind HIV-1 MA protein strongly |
|
P-20 |
Masateru Hiyoshi
[Kumamoto Univ.] |
HIV-1 Nef Perturbs Function, Structure and Signaling of the Golgi through
a Src Kinase Hck |
|
P-21 |
Nopporn Chutiwitoonchai
[Kumamoto Univ.] |
Effect of a small compound and an Hck mutant on HIV-1 infectivity |
|
P-22 |
Takashi Chihara
[Kumamoto Univ.] |
Effect of Nef on anti-inflammatory M2-macrophages |
|
P-23 |
Shinichiro Hattori
[Kumamoto Univ.] |
The kinetic analysis of Foxp3+CD4+ regulatory T cells in HIV-1 infection |
|
P-24 |
Ryusho Kariya
[Kumamoto Univ.] |
HIV protease inhibitor inhibits the growth of primary effusion lymphoma
and induces apoptosis |
|
P-25 |
Zafrul Hasan
[Kumamoto Univ.] |
Implication of the effects of host immune responses on the HIV-1 vpu
gene evolution |
|
P-26 |
Philip Mwimanzi
[Kumamoto Univ.] |
Nef activity in down regulation of viral receptors and protection of HIV
superinfection is modulated by Nef mutations that confer CTL escape
during acute infection |
|
P-27 |
Nobutoki Takamune
[Kumamoto Univ.] |
Potential low protein expression property of Nef |
|
P-28 |
Yusuke Nakano
[Kumamoto Univ.] |
Modification of coreceptor oligomerization by coreceptor inhibitors |
|
P-29 |
Hiromi Terasawa
[Kumamoto Univ.] |
Complete Resistance to Maraviroc in R5 HIV-1 with gp120 V3 Loop Mutations Is Affected by T199K and/or T275M in Env |
|
P-30 |
Nobuyo Higashi-Kuwata
[Kumamoto Univ.] |
Early phase dynamics of HIV-1 infection in hPBM-transplanted NOD/SCID/Jak3-/- mice using infectious HIV-1 carrying fluorescent protein mCherry |
|
P-31 |
Hiromi Ogata-Aoki
[Kumamoto Univ.] |
Early Phase Dynamics of HIV Infection in hPBMC-Transplanted NOD/SCID/Jak3-/- Mice Using Infectious HIV Carrying a Fluorescent Protein, mCherry: 2 |
|
P-32 |
Yoshinori Sato
[Kumamoto Univ.] |
Failure of effector function of human CD8+ T cells in NOD/SCID/Jak3-/- mice transplanted with human CD34+ hematopoietic stem cells |
|
P-33 |
Masao Hashimoto
[Kumamoto Univ.] |
HIV-1 specific HLA-B*5401-restricted Pol155-specific CTLs include distinct CTL repertoire with different antigen specificity against epitope variant |
|
P-34 |
Nozomi Kuse
[Kumamoto Univ.] |
Long-term control of HIV-1 infection in HLA-B*5101+ Japanese hemophiliacs |
|
P-35 |
Takuya Naruto
[Kumamoto Univ.] |
Selection of HLA-B57-associated Gag A146P mutant by HLA-B*4801-resticted CTLs in HLA-B57-negative Japanese cohort |
|
P-36 |
Kazutaka Honda
[Kumamoto Univ.] |
Selection of HIV-1 escape mutant by HLA-Cw*1202-restricted
Pol-specific cytotoxic T lymphocytes having a strong ability to suppress HIV-1 replication |
|
P-37 |
Tomohiro Akahoshi
[Kumamoto Univ.] |
HIV-1-specific cytotoxic T lymphocytes having cross-recognition for
escape mutation |
|
P-38 |
Tamayo Watanabe
[Univ. of Toyama / Kumamoto
Univ.] |
Identification and characterization of 5 novel HIV-1 Integrase-specific
HLA-B*4002-restricted CTL epitopes |
|
P-39 |
Madoka Koyanagi
[Kumamoto Univ.] |
HIV-1-specific CD4+ T cell response to HIV-1 Nef, Gag and Pol in
Japanese cohort |
|
P-40 |
Hayato Murakoshi
[Kumamoto Univ.] |
Comprehensive analysis of HIV-1-specific CD8+ T cell responses in
chronically HIV-1-infected Japanese cohort |
|
P-41 |
Takayuki Chikata
[Kumamoto Univ.] |
HLA-Associated Viral Polymorphism in Chronically HIV-1 Infected
Japanese Cohort |
|
P-42 |
Jagdagsuren Davaalkham
[NCGM] |
Emergence of HIV-1 Subtype B outbreak in Mongolia |
|
P-43 |
Koji Watanabe
[NCGM / Kumamoto Univ.] |
Clinical features of amoebic diseases in HIV-infected individuals in Japan |
|
P-44 |
Tsunefusa Hayashida
[NCGM / Kumamoto Univ.] |
Trends in early identification of HIV infection in Tokyo analyzed by BED
assay |
|
P-45 |
Takeshi Nishijima
[NCGM] |
The impact of weight on Tenofovir-induced renal dysfunction among
Japanese patients with HIV-1 infection |
|
P-46 |
Takayoshi Koyama
[NCGM] |
Integration into DNA double-strand break sites of HIV-1 is not attenuated by raltegravir, an integrase inhibitor |
|
P-47 |
Kazuhiko Ide
[Kumamoto Univ.] |
Novel HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) and a novel polycyclic ligand |
|
P-48 |
Manabu Aoki
[Kumamoto Health Science
Univ.] |
Tipranavir-resistant HIV-1 loses both protease enzymatic inhibition and dimerization inhibition activity |
|
P-49 |
Masayuki Amano
[Kumamoto Univ.] |
Inserts in Gag Proteins Elicit Degradation of the Gag Proteins in Multi-drug-resistant HIV Variants |
|
P-50 |
Matthew L. Danish
[Kumamoto Univ.] |
Emergence of HIV-1 Variants Highly Resistant to Darunavir and the Resistance Mechanism |
|
P-51 |
P. Miguel Salcedo-Gomez
[Kumamoto Univ.] |
An unreported insert QQATADT in the Gag-encoding region of HIV-1 isolated from a treatment-experienced HIV-1-infected patients |